Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Karyopharm Therapeutics nets $116mm through initial public offering
11 Dec 2013
Karyopharm Therapeutics Inc. (developing novel treatments for cancer and inflammatory conditions) netted $116mm through its initial public offering of 7.8mm common shares (including the overallotment) at $16. The company filed in October, at the time hoping to sell 5.67mm shares for between $14-16.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?